"M42": Launching a new operating structure to promote innovation in global healthcare
Abu Dhabi, January 23 / WAM / M42 International Medical Group announced today the launch of a new operational structure aimed at enhancing innovation in healthcare, focusing business on strategic priorities, and accelerating the growth of local and international business.
The new structure includes the establishment of four new platforms under “M42” to support the group’s strategic ambitions for growth, including internal and external growth, expansion into new markets, forming influential and effective partnerships to bridge the gaps in global health care, and harnessing artificial intelligence to bring about a qualitative transformation in healthcare systems. Traditional health care.
Under the new structure, M42 will focus on strategic planning, strategic mergers and acquisitions, corporate finance, strategic human resources, legal affairs, strategic communications, global procurement, internal audit, and risk management.
The new operational model includes the establishment of four platforms that operate with a greater degree of independence, responsibility and accountability, in the context of the “M42” group’s endeavor to grow, expand and achieve the common ambition.
These platforms include the “Global Patient Care” platform, which was established through the merger of Emirati and international health institutions as a leading institution in global health care, as it operates 480 clinics in 26 countries and provides its services to 15 million patients annually. Its comprehensive services include kidney care, treatment Chronic disease and outpatient management, diagnostics, women’s and children’s health, specialty surgery, and long-term care.
Dimitrismoulavasilis, CEO of Diaverm, part of the M42 Group, and Acting Chief Operating Officer of the M42 Group, has been appointed CEO of this platform.
To support this initiative, Dr. Ali Anis will serve as Chief Operating Officer of the Global Patient Care Platform in the UAE and Bahrain, while Dr. Mai Al Jaber will serve as Chief Executive Officer of Outpatient Care, while Dr. Laila Abdel-Wareth will serve as Chief Diagnostics Officer, and Dr. Sumaya Zaher will serve as Chief Executive Officer of Outpatient Care. Chief Executive Officer of the Women and Child Care Sector.
The “Integrated Health Solutions” platform focuses on national programs and population health, and aims to address global health disparities through precise, preventive and predictive care. Through this platform, “M42” will focus on genomics, national programs, biobanking, data services, environmental sciences, and research. Clinical and trials, while Dr. Fahd Al Marzouqi will assume the position of CEO of this platform.
The “Digital Health Solutions” platform works to benefit from the success of initiatives such as “Malafi” and expand the scope of digital health innovations and solutions supported by artificial intelligence to improve patient outcomes, empower healthcare providers and health ecosystems, and improve access to healthcare inside and outside the UAE. Karim Shaheen is the CEO of the platform.
The pioneering “Life Sciences with Artificial Intelligence” platform targets drug discovery and development, harnesses artificial intelligence and partnerships across the life sciences value chain, and builds “M42” capabilities in this field, as Dr. Fahd Al Marzouqi will serve as acting CEO of the platform until a CEO is appointed.
Underpinning all platforms will be M42 Group’s continued focus on cloud computing, modern technologies and engineering, enabling these platforms to deliver their services to individuals, communities and countries.
Hassan Jassim Al Nowais, Managing Director and CEO of the “M42” Group, said in a statement to the Emirates News Agency, “WAM,” that the new “M42” operational model is more than just a structural change, as it is a strategic business development designed to unleash the group’s full capabilities in care. Global health.
He added that the new structure will enable the group’s platforms and human resources to seize growth opportunities, expand its scope and footprint, accelerate innovation in healthcare, and create a qualitative shift in healthcare systems at the global level. This is not just an evolution of “M42”, but rather an important chapter in a growth journey. The group aims to make a positive impact on the lives of individuals locally and globally.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
